SONX Sonendo, Inc.
Dental Equipment & Supplies · OTC · SEC CIK 1407973 · Fiscal year ends 12/31
Financial factors as of 2024-12-31 (2024Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY-4.1%
TTM net income YoY54.0%
TTM EPS YoY54.5%
Revenue 3-yr CAGR0.0%
Net income 3-yr CAGR—
Margins
Gross margin35.7%
Operating margin-88.5%
Net margin-84.4%
FCF margin-74.7%
EBITDA margin-87.6%
Returns
ROE-166.8%
ROA-51.2%
ROIC (approx.)-75.8%
Asset turnover0.61x
Leverage & solvency
Liabilities / assets83.4%
Debt / equity2.78x
Current ratio1.39x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.88x
Accruals ratio-6.2%
Payout ratio—
Capex / revenue0.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2024Q4*2024-12-31 | 2024Q32024-09-30 | 2024Q22024-06-30 | 2024Q12024-03-31 | 2023Q4*2023-12-31 | 2023Q32023-09-30 | 2023Q22023-06-30 | 2023Q12023-03-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $9.80M | $8.04M | $8.31M | $7.05M | $9.02M | $8.16M | $8.76M | $8.68M |
| Cost of revenue | $4.89M | $4.73M | $5.20M | $5.05M | $6.73M | $7.28M | $9.25M | $6.70M |
| Gross profit | $3.42M | $3.31M | $3.12M | $2.00M | $2.29M | $884,000 | -$485,000 | $1.98M |
| R&D expense | $1.41M | $1.59M | $1.57M | $2.19M | $1.97M | $2.79M | $2.76M | $2.93M |
| SG&A expense | $3.40M | $4.87M | $4.16M | $10.06M | $4.54M | $7.71M | $6.42M | $14.11M |
| Operating income | -$5.64M | -$6.79M | -$6.69M | -$10.25M | -$10.28M | -$16.57M | -$17.36M | -$15.06M |
| Interest expense | $863,000 | $1.01M | — | — | $1.68M | $1.65M | — | — |
| Pretax income | -$6.37M | -$7.54M | -$7.45M | -$12.19M | -$11.27M | -$17.45M | -$18.10M | -$15.64M |
| Net income | -$6.37M | -$7.54M | -$7.37M | -$6.76M | -$10.88M | -$16.98M | -$17.69M | -$15.37M |
| EBITDA | -$5.56M | -$6.72M | -$6.61M | -$10.19M | -$10.26M | -$16.18M | -$16.99M | -$14.72M |
| EPS (basic) | — | -15.77 | -0.08 | -0.07 | — | -36.02 | -0.19 | -0.16 |
| EPS (diluted) | — | -15.77 | -0.08 | -0.07 | — | -36.02 | -0.19 | -0.16 |
| Weighted avg. shares (diluted) | — | 477,857 | 95.43M | 94.82M | — | 471,427 | 93.68M | 93.39M |
| Balance sheet | ||||||||
| Cash & equivalents | $10.23M | $13.10M | $15.70M | $18.58M | $14.01M | $12.09M | $12.57M | $12.65M |
| Short-term investments | $1.40M | $4.19M | $8.53M | $15.01M | $32.77M | $43.85M | $53.32M | $62.30M |
| Receivables | $3.68M | $4.45M | $4.53M | $4.18M | $4.79M | $5.60M | $6.31M | $6.43M |
| Inventory | $10.21M | $11.49M | $11.80M | $12.12M | $11.07M | $11.44M | $13.16M | $15.97M |
| Current assets | $27.80M | $34.72M | $42.51M | $52.65M | $65.27M | $75.49M | $87.21M | $106.44M |
| PP&E, net | $0 | $691,000 | $766,000 | $767,000 | $664,000 | $216,000 | $2.78M | $2.84M |
| Goodwill | — | — | — | — | $8.45M | $8.45M | $8.45M | $8.45M |
| Intangibles | — | — | — | — | $661,000 | $748,000 | $1.96M | $2.13M |
| Total assets | $31.27M | $38.13M | $46.30M | $56.77M | $78.16M | $88.33M | $104.14M | $123.91M |
| Current liabilities | $19.94M | $19.11M | $17.73M | $18.95M | $35.32M | $11.05M | $11.35M | $15.23M |
| Short-term debt | $10.80M | $10.80M | $10.80M | $10.80M | $24.90M | — | — | — |
| Long-term debt | $3.64M | $6.08M | $8.51M | $10.91M | $12.47M | $37.20M | $37.04M | $36.89M |
| Total debt | $14.44M | $16.88M | $19.31M | $21.71M | $37.37M | $37.20M | $37.04M | $36.89M |
| Total liabilities | $26.07M | $27.16M | $28.43M | $32.24M | $49.74M | $50.55M | $51.09M | $55.33M |
| Shareholders' equity | $5.19M | $10.97M | $17.87M | $24.53M | $28.42M | $37.78M | $53.04M | $68.58M |
| Net debt | $4.21M | $3.79M | $3.61M | $3.13M | $23.36M | $25.11M | $24.48M | $24.24M |
| Shares outstanding | 427,330 | 418,038 | 72.83M | 70.45M | 317,737 | 52.97M | 52.66M | 51.25M |
| Cash flow statement | ||||||||
| Operating cash flow | -$2.93M | -$4.31M | -$6.72M | -$10.69M | -$9.51M | -$10.22M | -$9.37M | -$16.98M |
| Capital expenditure | $0 | $0 | $15,000 | $146,000 | $86,000 | $216,000 | $417,000 | $210,000 |
| Free cash flow | -$2.93M | -$4.31M | -$6.73M | -$10.84M | -$9.59M | -$10.43M | -$9.78M | -$17.19M |
| Investing cash flow | $2.77M | $4.42M | $6.55M | $32.07M | $11.42M | $9.84M | $9.18M | $11.96M |
| Financing cash flow | -$2.71M | -$2.71M | -$2.71M | -$16.81M | $1,000 | -$100,000 | $109,000 | -$6,000 |
| Depreciation & amortization | $75,000 | $76,000 | $73,000 | $64,000 | $24,000 | $384,000 | $371,000 | $339,000 |
| Stock-based compensation | $600,000 | $630,000 | $703,000 | $2.89M | $1.49M | $1.78M | $2.06M | $1.94M |
Free plan shows the latest 8 periods; Pro shows all 20 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.